Back

PCF 2020 - 27th Annual Prostate Cancer Foundation Scientific Retreat (Virtual Meeting)

Oct 20 - Oct 23, 2020 | CarlsbadCAUS

LARVOL is not affiliated with 27th Annual Prostate Cancer Foundation Scientific Retreat (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners

Condition
Stage
Treatment
Setting
Biomarker
Trial Name/ID

Showing 5 abstracts linked to Trials

[VIRTUAL] A Phase 2 Study of the Polo-like kinase 1 (PLK1) inhibitor, Onvansertib, in Combination with Abiraterone in Patients with Abiraterone (Abi)-Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC)

[VIRTUAL] Preoperative Trial of Neo Adjuvant Abiraterone Plus Or MInus Cabazitaxel: Early Results

[VIRTUAL] EPI-7386, a potent N-terminal domain androgen receptor inhibitor, with a favorable preclinical safety and superior in vitro/in vivo profile, in clinical development for prostate cancer

  • Poster

[VIRTUAL] Identification of Novel Therapies for RB-deficient Castration-Resistant Prostate Cancer

  • Poster

[VIRTUAL] Novel Immunotherapy Combinations Against Castration-Resistant Prostate Cancer

  • Poster